Article
Myelodysplastic syndromes.
Blood - 15 May 2008
Nimer Stephen D
Abstract excerpt
There has been a remarkable explosion of knowledge into the molecular defects that underlie the acute and chronic leukemias, leading to the introduction of targeted therapies that can block key cellular events essential for the viability of the leukemic cell. Our understanding of the pathogenesis of the myelodysplastic syndromes (MDSs) has lagged behind, at least in part, because they represent a more...
Topics
- Animals
- Drug Delivery Systems
- Drug Therapy
- Humans
- Mutation
- Myelodysplastic Syndromes
- Prognosis